The Molybdenum-Technetium Generator Revision Notes | A Level AQA Physics

1. The Problem: Getting a Short-Lived Isotope to the Patient

Picture a hospital that needs a radioactive tracer for a patient's bone scan. The ideal tracer decays quickly — short enough to minimise radiation dose, but long enough to complete the scan. The catch: if the half-life is only 6 hours, you cannot order it from a distant supplier and wait two days for delivery. By the time it arrives, most of it has gone.

This is the central challenge of radionuclide imaging. The molybdenum-technetium generator solves it elegantly by producing the short-lived isotope on-site, on demand, every single day.

2. The Parent-Daughter Relationship: Mo-99 and Tc-99m

The generator exploits a nuclear decay chain. Molybdenum-99 ($^{99}_{42}\text{Mo}$) is the parent nuclide. It undergoes beta-minus decay, emitting a beta particle and an antineutrino, to produce technetium-99m ($^{99m}_{43}\text{Tc}$). The lowercase 'm' stands for metastable — a higher-energy nuclear state that has not yet settled to its ground state.

When Tc-99m de-excites, it emits a single gamma photon of energy 140 keV. This transition — from the metastable state to the ground state of Tc-99 — is what makes it so clinically useful. No alpha or beta particles are emitted during this step, which means the patient receives a lower radiation dose from the tracer itself.

The full decay sequence can be written as:

Tc-99m then de-excites to its ground state by isomeric transition:

3. Why Tc-99m Is the Ideal Diagnostic Radionuclide

Not every radioactive isotope is suitable for use inside a patient. Tc-99m has a combination of properties that make it almost uniquely well-suited to diagnostic nuclear medicine, and understanding each property is important for exam questions that ask you to evaluate or justify its use.

The 140 keV gamma energy is worth dwelling on. Gamma photons that are too low in energy are absorbed by the patient's body before reaching the detector. Photons that are too high in energy pass straight through the detector without being absorbed. At 140 keV, Tc-99m sits in a practical window where detection efficiency is high.

4. How the Generator Works: Structure and Elution

The generator itself is a compact, shielded device — roughly the size of a large thermos flask — that sits in the hospital's radiopharmacy. Inside, Mo-99 is bound to an alumina (aluminium oxide) column. Tc-99m, as it is continuously produced by the decay of Mo-99, is not chemically bound to the column in the same way and can be washed off.

The extraction process is called elution. A sterile saline solution (sodium chloride in water) is passed through the column. The Tc-99m dissolves into the saline as sodium pertechnetate ($\text{NaTcO}_4$) and is collected in a sterile vial. The Mo-99 remains bound to the alumina column and continues producing fresh Tc-99m.

Because Mo-99 has a half-life of approximately 66 hours, the generator can be eluted roughly once per day. After each elution, Tc-99m begins to build up again as Mo-99 continues to decay. The generator is typically replaced every one to two weeks, when the Mo-99 activity has fallen to a level that no longer yields a clinically useful quantity of Tc-99m.

5. Half-Lives and the Generator's Practical Design

The relationship between the two half-lives is what makes the generator viable. Mo-99 at ~66 hours is long-lived enough to survive transport from a nuclear reactor or cyclotron facility to a hospital — a journey that might take 24-48 hours. If Mo-99 had a half-life of only a few hours, it would be largely decayed before it arrived.

At the same time, Tc-99m at ~6 hours is short enough to limit the patient's radiation exposure. After a scan, the Tc-99m in the patient's body decays to negligible activity within about 24 hours (four half-lives reduce activity to $\frac{1}{16}$ of the original; ten half-lives reduce it to less than 0.1%).

Worked example: Calculating Remaining Tc-99m Activity After a Scan

A patient is administered Tc-99m with an initial activity of 600 MBq at 09:00. The scan is complete by 11:00. Calculate the activity remaining in the patient at 21:00 the same day. (Half-life of Tc-99m = 6 hours.)

1. From 09:00 to 21:00 = 12 hours — We measure time from when the activity was administered, not from when the scan ended.
2. $n = \frac{t}{t_{1/2}} = \frac{12}{6} = 2$ half-lives — Each half-life of 6 hours halves the remaining activity.
3. $A = A_0 \times \left(\frac{1}{2}\right)^n = 600 \times \left(\frac{1}{2}\right)^2$ — The general formula for activity after n half-lives. $A_0$ is the initial activity.
4. $\left(\frac{1}{2}\right)^2 = \frac{1}{2} \times \frac{1}{2} = \frac{1}{4}$ — Two half-lives means the activity has halved twice.
5. $A = 600 \times \frac{1}{4} = 150 \text{ MBq}$ — The activity has fallen to one quarter of its original value after 12 hours.
6. After 1 half-life (6 h): 300 MBq. After 2 half-lives (12 h): 150 MBq. Consistent. — Stepping through each half-life individually confirms the answer.

Answer: 150 MBq at 21:00

This rapid decay is a significant safety advantage. A patient who has undergone a Tc-99m scan does not remain significantly radioactive for long, which simplifies post-procedure care and reduces radiation exposure to family members and healthcare workers.

6. Clinical Importance and Wider Context

Tc-99m is used in approximately 80% of all nuclear medicine diagnostic procedures worldwide. It can be attached to a wide range of pharmaceutical molecules — called radiopharmaceuticals — that are designed to accumulate in specific tissues. For example, when attached to a phosphate compound, it concentrates in bone and can reveal fractures, tumours, or infection that would be invisible on a standard X-ray.

The generator system is what makes this scale of use possible. Without it, hospitals would need to be located within a few hours of a nuclear reactor or cyclotron, and the logistics of supplying short-lived isotopes would be prohibitive. The generator decouples production from use: Mo-99 is produced centrally and shipped globally, while Tc-99m is generated locally on demand.

Mo-99 itself is produced by neutron bombardment of uranium-235 targets in nuclear reactors, or by proton bombardment in cyclotrons. The global supply chain for Mo-99 is therefore a critical piece of medical infrastructure — disruptions to reactor supply have caused genuine shortages of Tc-99m in the past, highlighting how dependent modern diagnostic medicine has become on this single generator system.

7. Exam Technique and Common Mistakes

Questions on the Mo-Tc generator appear in the medical physics section and tend to use command words such as 'explain', 'evaluate', and 'suggest'. Here is how to approach each type with precision.

When asked to explain why Tc-99m is suitable, you need to link each property to a consequence. Saying 'it has a short half-life' alone is not enough — you must add 'which limits the radiation dose received by the patient'. Similarly, 'it emits gamma radiation' must be followed by 'which can penetrate tissue and be detected externally by a gamma camera'.

When asked to explain the role of Mo-99, be precise: Mo-99 is the parent nuclide that undergoes beta-minus decay to produce Tc-99m. It is bound to the alumina column and is not eluted. Its longer half-life (~66 hours) allows the generator to be transported and used over several days before the activity becomes too low.

The Mo-Tc generator is a precise solution to a genuine logistical problem in medical physics: it separates the production of a long-lived parent from the clinical use of a short-lived daughter, making Tc-99m available on demand in hospitals worldwide — and that is why it underpins the majority of nuclear medicine diagnostic procedures today.